Washington, D.C. – In response to a joint release from the U.S. Food & Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) ... Read More
FDA Regulation of LDTs is Misguided; Requires Congressional Authorization Washington, D.C. – The American Clinical Laboratory Association (ACLA) today submitted comments urging the U.S. Food ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today issued the following statement after the U.S. Food and Drug Administration (FDA) released a proposed ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA), along with 44 stakeholders, sent a letter to Medicare Administrative Contractors (MACS), Novitas Solutions Medical Affairs ... Read More
Washington, D.C. – The American Clinical Laboratory Association has joined with more than 30 health care provider organizations to urge House and Senate leadership to protect ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today issued the following statement as the federal government’s formal declaration of a Public Health Emergency (PHE) ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) released the following statement in response to the Biden-Harris Administration designating fentanyl-xylazine as an emerging threat: “The ... Read More